RCEL analyst estimates
Avita Medical (RCEL) analyst ratings, the average price target and its range, and every firm's latest call.
RCEL analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Aug 28, 2026 | Lake Street | Avita Medical price target raised to $12 from $8 at Lake Street | $12.00 |
| Aug 19, 2026 | BTIG | Avita Medical Ltd. (RCEL) PT Raised to $11 at BTIG | $11.00 |
| Aug 7, 2026 | BTIG | BTIG Upgrades Avita Medical Ltd. (RCEL) to Buy | $7.00 |
| May 15, 2026 | Lake Street | Avita Medical upgraded to Buy from Hold at Lake Street | $6.00 |
| Mar 26, 2026 | Northland Securities | Avita Medical stock pullback creates buying opportunity, says Northland | $10.00 |
| Jan 16, 2026 | Lake Street | Avita Medical price target raised to $3.50 from $3 at Lake Street | $3.50 |
| Oct 17, 2025 | Lake Street | Avita Medical downgraded to Hold from Buy at Lake Street | $4.00 |
| Jan 8, 2025 | Lake Street | Avita Medical price target lowered to $14 from $20 at Lake Street | $14.00 |
| May 14, 2024 | Piper Sandler | Piper Sandler Downgrades Avita Medical Ltd. (RCEL) to Neutral | $9.00 |
- 5 firms rate RCEL: 5 buy, 0 hold, 0 sell.
- The average price target is $11.50 from 2 analysts, from $11.00 to $12.00.
Updated 2026-11-06 11:42 UTC